Skip to main content

Advertisement

SpringerLink
Log in

Invasive pneumococcal disease in children in Ireland—the anticipated benefit of conjugate pneumococcal vaccination

  • Original Article
  • Published:
Irish Journal of Medical Science Aims and scope Submit manuscript

Abstract

Background

Streptococcus pneumoniae is an important cause of childhood illness. Recently a safe and effective 7-valent conjugate pneumococcal vaccine for children has been licensed in the EU.

Aims

To calculate the incidence of invasive pneumococcal disease (IPD) in children in Ireland, to estimate the burden of disease and to anticipate the protective effect of the conjugate vaccine.

Methods

Retrospective review of data from children with IPD.

Results

Ninety-six cases of IPD in 95 children including two related deaths were identified. All childhood IPD incidence was estimated at 10.6/100,000. We anticipate that the 7-valent conjugate vaccine could prevent up to 90% of sepsis and up to 82.5% of meningitis cases.

Conclusions

IPD is an important cause of mortality and morbidity in children in Ireland. Routine use of conjugate pneumococcal vaccine would have a significant impact on pneumococcal disease, especially in vaccinated children but also in unvaccinated children and older adults.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Overturf GD, the Committee on Infectious Diseases (2000) Technical report: prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis. Pediatrics 106:367–376

    Article  PubMed  CAS  Google Scholar 

  2. Ispahani P, Slack RCB, Donald FE et al (2004) Twenty year surveillance of invasive pneumococcal disease in Nottingham: serogroups responsible and implications for immunisation. Arch Dis Child 89:757–762

    Article  PubMed  CAS  Google Scholar 

  3. Campbell GD Jr, Silberman R (1998) Drug resistant Streptococcus pneumoniae (Review). Clin Infect Dis 26:1188–1195

    Article  PubMed  Google Scholar 

  4. Clarke P, Murchan S, Smyth EG, Humphreys H (2004) Antimicrobial susceptibility of invasive isolates of Streptococcus pneumoniae in Ireland. Clin Microbiol Infect 10:657–659

    Article  PubMed  CAS  Google Scholar 

  5. http://www.ndsc.ie/hpsc/A-Z/MicrobiologyAntimicrobialResistance/EuropeanAntimicrobialResistanceSurveillanceSystemEARSS/ EARSSSurveillanceReports/. Accessed 13 March 2008

  6. http://www.emea.europa.eu/humandocs/Humans/EPAR/prevenar/prevenar.htm. Accessed 13 March 2008

  7. Hausdorff WP, Bryant J, Paradiso PR et al (2000) Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part 1. Clin Infect Dis 30:100–121

    Article  PubMed  CAS  Google Scholar 

  8. Hausdorff WP, Bryant J, Kloek C et al (2000) The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part 2. Clin Infect Dis 30:122–140

    Article  PubMed  CAS  Google Scholar 

  9. Eskola J, Anttila M (1999) Pneumococcal conjugate vaccines. Pediatr Infect Dis J 18:543–551

    Article  PubMed  CAS  Google Scholar 

  10. Black S, Shinefield H, Fireman B et al (2000) Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 3:187–195

    Google Scholar 

  11. Haddy RI, Perry K, Chacko CE et al (2005) Comparison of incidence of invasive Streptococcus pneumoniae disease among children before and after introduction of conjugated pneumococcal vaccine. Pediatr Infect Dis J 4:320–333

    Google Scholar 

  12. Poehling KA, Lafleur BJ, Szilagyi PG et al (2004) Population-based impact of pneumococcal conjugate vaccine in young children. Pediatrics 114:755–761

    Article  PubMed  Google Scholar 

  13. Lexau CA, Lynfield R, Danila R et al (2005) Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 294:2043–2051

    Article  PubMed  CAS  Google Scholar 

  14. http://www.eurosurveillance.org/ew/2006/061207.asp#3. Accessed 13 March 2008

  15. http://www.cso.ie/census/documents/vol2_t10_t11_t13.pdf. Accessed 13 March 2008

  16. http://www.cso.ie/px/pxeirestat/database/eirestat/Population.asp. Accessed 13 March 2008

  17. Hausdorff WP, Siber G, Paradiso PR (2001) Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children. Lancet 357(9260):950–952

    Article  PubMed  CAS  Google Scholar 

  18. Jefferson T, Ferroni E, Curtale F et al (2006) Streptococcus pneumoniae in western Europe: serotype distribution and incidence in children less than 2 years old. Lancet Infect Dis 7:405–410

    Article  Google Scholar 

  19. McIntosh ED, Booy R (2002) Invasive pneumococcal disease in England and Wales: what is the true burden and what is the potential for prevention using 7 valent pneumococcal conjugate vaccine? Arch Dis Child 86(6):403–406

    Article  PubMed  CAS  Google Scholar 

  20. Eskola J, Takala AK, Kela E et al (1992) Epidemiology of invasive pneumococcal infections in children in Finland. JAMA 268(23):3323–3327

    Article  PubMed  CAS  Google Scholar 

  21. Christie DJ, Coleman DJ, Wan X et al (2002) Childhood invasive pneumococcal disease in Tasmania, 1994–2000. J Paediatr Child Health 38(5):445–449

    Article  PubMed  CAS  Google Scholar 

  22. Juven T, Mertsola J, Toikka P, Virkki R, Leinonen M, Ruuskanen O (2001) Clinical profile of serologically diagnosed pneumococcal pneumonia. Pediatr Infect Dis J 20(11):1028–1033

    Article  PubMed  CAS  Google Scholar 

  23. Black SB, Shinefield HR, Ling S et al (2002) Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J 21(9):810–815

    Article  PubMed  Google Scholar 

  24. http://www.esri.ie/health_information/hipe/. Accessed 13 March 2008

  25. McIntosh ED, Fritzell B, Fletcher MA (2006) Burden of paediatric invasive pneumococcal disease in Europe, 2005. Epidemiol Infect 135:644–656

    Article  PubMed  Google Scholar 

  26. Black S, Shinefield H (2002) Safety and efficacy of the seven-valent pneumococcal conjugate vaccine: evidence from Northern California. Eur J Pediatr 161:S127–S131

    Article  PubMed  Google Scholar 

  27. Kyaw MH, Lynfield R, Schaffner W et al (2006) Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 354(14):1455–1463

    Article  PubMed  CAS  Google Scholar 

  28. Musher DM (2006) Pneumococcal vaccine—direct and indirect (“herd”) effects. N Engl J Med 354(14):1522–1524

    Article  PubMed  CAS  Google Scholar 

  29. McIntosh ED, Conway P, Willingham J et al (2005) Pneumococcal pneumonia in the UK—how herd immunity affects the cost-effectiveness of 7-valent pneumococcal conjugate vaccine (PCV). Vaccine 23(14):1739–1745

    Article  PubMed  CAS  Google Scholar 

  30. Kopterides P, Falagas ME (2000) Potential consequences of the pneumococcal conjugate vaccine. N Engl J Med 355(1):95; author reply 95–96

    Article  Google Scholar 

  31. Huang SS, Platt R, Rifas-Shiman SL et al (2005) Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics 116:e408–e413

    Article  PubMed  Google Scholar 

  32. Messina AF, Katz-Gaynor K, Barton T et al (2007) Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005. Pediatr Infect Dis J 26(6):461–467

    Article  PubMed  Google Scholar 

  33. Pebody RG, Hellenbrand W, D’Ancona F et al (2006) Pneumococcal disease surveillance in Europe. Euro Surveill 11(9):171–178

    PubMed  CAS  Google Scholar 

  34. Kayhty H, Ahman H, Eriksson K et al (2005) Immunogenicity and tolerability of a heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 12 months of age. Pediatr Infect Dis J 24(2):108–114

    Article  PubMed  Google Scholar 

Download references

Competing interests

None.

Author information

Authors and Affiliations

  1. Department of Paediatric Infectious Diseases, Our Lady’s Children’s Hospital, Crumlin, Dublin 12, Ireland

    J. J. Fitzsimons, A. L. Chong & K. M. Butler

  2. The Children’s University Hospital, Temple Street, Dublin 2, Ireland

    M. T. Cafferkey

Authors
  1. J. J. Fitzsimons
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. L. Chong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. T. Cafferkey
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. M. Butler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. J. Fitzsimons.

Additional information

Prior to publication, data from this study was made available to the Health Protection Surveillance Centre (HSPC) in Ireland. These data contributed to the decision by the National Immunisation Advisory Committee to recommend the introduction of an universal childhood pneumococcal vaccination programme. This is currently expected to commence in September 2008.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fitzsimons, J.J., Chong, A.L., Cafferkey, M.T. et al. Invasive pneumococcal disease in children in Ireland—the anticipated benefit of conjugate pneumococcal vaccination. Ir J Med Sci 177, 225–231 (2008). https://doi.org/10.1007/s11845-008-0167-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-008-0167-6

Keywords

Search

Navigation